WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
Meta (META.US) acquires Accelerated AI race worth re-evaluation AI intelligent body concept outbreak MARKETINGFORCE (02556) closes up 5.83%
US Stock Market Move | Storage concept stocks increase, SanDisk (SNDK.US) soars more than 11%.
US Stock Market Move | AI energy concept stocks collectively rise, Bloom Energy (BE.US) increases by more than 8%.
Meta (META.US) acquires Accelerated AI race worth re-evaluation AI intelligent body concept outbreak MARKETINGFORCE (02556) closes up 5.83%
US Stock Market Move | Storage concept stocks increase, SanDisk (SNDK.US) soars more than 11%.
US Stock Market Move | AI energy concept stocks collectively rise, Bloom Energy (BE.US) increases by more than 8%.
